LPL | Lipoprotein lipase | Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
LRRC2 | Leucine rich repeat containing 2 | | | | | | Group enriched |
MLF1 | Myeloid leukemia factor 1 | Cancer-related genes Disease related genes
| | | | | Group enriched |
MURC | Muscle-related coiled-coil protein | | | | | | Group enriched |
MYH6 | Myosin, heavy chain 6, cardiac muscle, alpha | Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | | | | Tissue enriched |
MYOM3 | Myomesin 3 | | | | | | Group enriched |
SH3BGR | SH3 domain binding glutamic acid-rich protein | | | | | | Group enriched |
SPHKAP | SPHK1 interactor, AKAP domain containing | | | | | | Group enriched |
SRPK3 | SRSF protein kinase 3 | Enzymes
| | | | | Group enriched |
TXLNB | Taxilin beta | | | | | | Group enriched |
TYRP1 | Tyrosinase-related protein 1 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CAND2 | Cullin-associated and neddylation-dissociated 2 (putative) | | | | | | Group enriched |
FGF1 | Fibroblast growth factor 1 (acidic) | Cancer-related genes FDA approved drug targets RAS pathway related proteins
| | | | | Group enriched |
KBTBD12 | Kelch repeat and BTB (POZ) domain containing 12 | | | | | | Group enriched |
MYH7B | Myosin, heavy chain 7B, cardiac muscle, beta | | | | | | Group enriched |
MYOZ2 | Myozenin 2 | Disease related genes
| | | | | Tissue enriched |
NT5C1A | 5'-nucleotidase, cytosolic IA | Enzymes
| | | | | Group enriched |
POPDC3 | Popeye domain containing 3 | Predicted membrane proteins
| | | | | Group enriched |
SPTB | Spectrin, beta, erythrocytic | Disease related genes Plasma proteins
| | | | | Group enriched |
AC005358.1 | | | | | | | Tissue enriched |
ASB15 | Ankyrin repeat and SOCS box containing 15 | | | | | | Group enriched |
ATP1A3 | ATPase, Na+/K+ transporting, alpha 3 polypeptide | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
C20orf26 | Chromosome 20 open reading frame 26 | Predicted membrane proteins
| | | | | Group enriched |
CAMK2B | Calcium/calmodulin-dependent protein kinase II beta | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
COQ10A | Coenzyme Q10 homolog A (S. cerevisiae) | Mitochondrial proteins
| | | | | Group enriched |
DCUN1D2 | DCN1, defective in cullin neddylation 1, domain containing 2 | | | | | | Group enriched |
DIRAS1 | DIRAS family, GTP-binding RAS-like 1 | | | | | | Group enriched |
DNAAF3 | Dynein, axonemal, assembly factor 3 | Disease related genes
| | | | | Group enriched |
ERBB4 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
FAM69C | Family with sequence similarity 69, member C | | | | | | Group enriched |
FRMD5 | FERM domain containing 5 | Cytoskeleton related proteins Predicted membrane proteins
| | | | | Group enriched |
GABRA4 | Gamma-aminobutyric acid (GABA) A receptor, alpha 4 | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
GUCA1C | Guanylate cyclase activator 1C | | | | | | Group enriched |
HCN2 | Hyperpolarization activated cyclic nucleotide-gated potassium channel 2 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
KCNA5 | Potassium voltage-gated channel, shaker-related subfamily, member 5 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
KLHL31 | Kelch-like family member 31 | | | | | | Group enriched |
MLIP | Muscular LMNA-interacting protein | | | | | | Group enriched |
MYO18A | Myosin XVIIIA | Cytoskeleton related proteins Plasma proteins
| | | | | Group enriched |
PPP1R1C | Protein phosphatase 1, regulatory (inhibitor) subunit 1C | | | | | | Group enriched |
PTP4A3 | Protein tyrosine phosphatase type IVA, member 3 | Enzymes
| | | | | Group enriched |
S100A1 | S100 calcium binding protein A1 | Cancer-related genes Plasma proteins
| | | | | Group enriched |
SGCA | Sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein) | Cytoskeleton related proteins Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
SGCG | Sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
SMYD1 | SET and MYND domain containing 1 | Enzymes
| | | | | Group enriched |
TBX20 | T-box 20 | Disease related genes Transcription factors
| | | | | Tissue enriched |
TBX5 | T-box 5 | Disease related genes Transcription factors
| | | | | Group enriched |
TENM2 | Teneurin transmembrane protein 2 | Predicted membrane proteins
| | | | | Tissue enriched |
TUBA8 | Tubulin, alpha 8 | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
CORO6 | Coronin 6 | | | | | | Group enriched |
FGF12 | Fibroblast growth factor 12 | RAS pathway related proteins
| | | | | Tissue enriched |